ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,876, issued on Sept. 23, was assigned to Massachusetts Eye and Ear Infirmary (Boston).
"Treatment of hearing loss by inhibition of casein kinase 1" was invented by Albert Edge (Brookline, Mass.) and Yenfu Cheng (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating hearing loss that include administering an inhibitor, e.g., a small molecule inhibitor, of casein kinase 1, preferably in combination with a treatment that stimulates Atoh1 gene expression, e.g., a gamma-secretase inhibitor, an Atoh1 stimulatory compound, or a GSK-3-beta inhibitor."
The patent was filed on Oct. 8, 2021, under Application No. 17/450,377.
*For furthe...